Indian Science Technology and Engineering facilities Map
 
Preivious Next  

  Digital Catalogue for Technology and Products Development


   Technology and Product Development

    Basic Information

Technology developed: Influenza Vaccines (TP19768472507)
Category: Nil
Details of Inventor(s):
Inventor Institution/Organization/Company Department Designation
Gayathri Bommakanti IISc MBU Former PhD student
Vamsee Mallajosyula IISc MBU Former PhD student
Raghavan Varadarajan IISC MBU Professor
Technical Application Area: Other
If 'Other', please specify:
Influenza vaccine
Please give more details of new technical application area:
Organization(s):
Indian Institute of Science (IISc) Bengaluru
Affiliated Ministry: Select One...
Type of technology development: Collaboration with Foreign Entity
Does the technology help in replacing any import items currently
procured from outside India?
Yes
Does the technology have export potential? Yes
Category of Technology developed: Export Potential
Stage of Development: Lab-scale
Please describe in detail including the TRL Level:
4

    Abstract:

Applications: Recombinant influenza vaccines with increased breadth of protection relative to current ones
Advantages: Recombinant influenza vaccines with increased breadth of protection relative to current ones see attached publications two representative publications 1 Bommakanti et al, PNAS 2010 2 Mallajosyula et al PNAS 2014

    Technology Inputs:

Imported Equipment/Spare Parts:
Equipment/Spare Parts Year ITC-HS Code
NA
Indigenous Equipment/Spare Parts:
Equipment/Spare Parts Year ITC-HS Code
NA
Imported Raw Materials:
Raw Materials Year ITC-HS Code
NA
Indigenous Raw Materials:
Raw Materials Year ITC-HS Code
NA
Existing R&D Facilities used:
Facilities Year ITC-HS Code
Facilities for protein characterization at IISc eg SPR 2008-09

   Patents & Publications:

Patents:
Filed Patents (No.) Granted Patents (No.) Year
2 2 2018-19
Publications:
Submitted (No.) Published (No.) Year
0 6 NA

    Commercialization Potential:

Who are the Potential Licensees? Already licenced to Mynvax Private Limited
What commercially available products address
the same problem?
Company Product Problem Addressed
Sanofi Influenza vaccines Influenza
Would you like to develop this invention further with
corporate research support?
Yes
Would you be interested in participating in cluster based
programs for commercialization research or business
planning for your invention?
Yes
      Submitted by: Prof KVS Hari Date of Submission: 26-11-2020



Chat Room      Write Review     Talk to Experts


THE VISION
THE MISSION
ABOUT I-STEM
It has always been the basic tenet of the Government of India, in generously funding R&D efforts at academic institutions over the years, that facilities established through such support be made available to those needing them and qualified to make use of them for their own research work
read more >>

However, this was never easy or straightforward for, among other reasons, there was no ready source of information of what facility was available and where. Thanks to the Web, it is much easier today to have a national and regional “inventory of resources”, so as to match users with the resources they need, and to do all this in an efficient and transparent manner.

This can lead to a leap in R&D productivity and greatly enhance the effectiveness of public investment. This is the motivation behind I-STEM.
read less <<
Visitor Hit Counter
Hosted at Indian Institute of Science
Copyright © 2024 I-STEM. All rights reserved.
Audited by: STQC Bengaluru.